81_FR_5493 81 FR 5472 - Center for Scientific Review; Notice of Closed Meetings

81 FR 5472 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 21 (February 2, 2016)

Page Range5472-5472
FR Document2016-01818

Federal Register, Volume 81 Issue 21 (Tuesday, February 2, 2016) 
[Federal Register Volume 81, Number 21 (Tuesday, February 2, 2016)]
[Notices]
[Page 5472]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-01818]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Member Conflict: Medical Imaging Investigations.
    Date: February 18, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Mehrdad Mohseni, MD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5211, MSC 7854, Bethesda, MD 20892, 301-435-
0484; [email protected].

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group, Diseases and Pathophysiology of the Visual 
System Study Section.
    Date: February 25-26, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bahia Resort Hotel, 998 West Mission Bay Drive, San 
Diego, CA 92109.
    Contact Person: Nataliya Gordiyenko, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5202, MSC 7846, Bethesda, MD 
20892, 301-435-1265; [email protected].

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group, Cancer Immunopathology and Immunotherapy Study 
Section.
    Date: February 25-26, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Dupont Hotel, 1500 New Hampshire Avenue NW., 
Washington, DC 20036.
    Contact Person: Denise R Shaw, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6158, MSC 7804, Bethesda, MD 20892, 301-435-
0198; [email protected].

    Name of Committee: Oncology 1--Basic Translational Integrated 
Review Group, Tumor Progression and Metastasis Study Section.
    Date: March 2-3, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Rolf Jakobi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6187, MSC 7806, Bethesda, MD 20892, 301-495-
1718; [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Member Conflict: Alcohol, Drugs and Neurotoxicology.
    Date: March 2-3, 2016.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael Selmanoff, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD 
20892, 301-435-1119; [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, PAR-13- 327: Innovative Molecular Analysis Technology 
Development for Cancer Research and Clinical Care.
    Date: March 2, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Zhang-Zhi Hu, MD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6186, MSC 7804, Bethesda, MD 20892, (301) 594-
2414; [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine, 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846- 93.878, 93.892, 
93.893, National Institutes of Health, HHS)

    Dated: January 27, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-01818 Filed 2-1-16; 8:45 am]
 BILLING CODE 4140-01-P

5472 Federal Register / Vol. 81, No. 21 / Tuesday, February 2, 2016 / Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued Number of Average Number of Total annual Activity responses per burden per Total hours respondents responses respondent response Total Youth Hours .............................................. ........................ ........................ ........................ .................................. 380 Total Hours .................................................. ........................ ........................ ........................ .................................. 1,899 1 There are no capital costs or operating and maintenance costs associated with this collection of information. FDA’s burden estimate is based on provisions set forth in sections Tumor Progression and Metastasis Study prior experience with research that is 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Section. similar to this proposed study. as amended. The grant applications and Date: March 2–3, 2016. Approximately 30,000 respondents will the discussions could disclose Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant complete a screener to determine confidential trade secrets or commercial applications. eligibility for participation in a study, property such as patentable material, Place: Embassy Suites at the Chevy Chase estimated to take approximately 2 and personal information concerning Pavilion, 4300 Military Road NW., minutes (0.03 hours), for a total of 900 individuals associated with the grant Washington, DC 20015. hours for screening activities. Three applications, the disclosure of which Contact Person: Rolf Jakobi, Ph.D., thousand respondents will complete a would constitute a clearly unwarranted Scientific Review Officer, Center for full study, estimated to last 20 minutes invasion of personal privacy. Scientific Review, National Institutes of (0.333 hours), for a total of 999 hours for Health, 6701 Rockledge Drive, Room 6187, Name of Committee: Center for Scientific completion of both adult studies and 1 MSC 7806, Bethesda, MD 20892, 301–495– Review Special Emphasis Panel, Member youth study. The estimated total hour 1718; jakobir@mail.nih.gov. Conflict: Medical Imaging Investigations. burden of the collection of information Date: February 18, 2016. Name of Committee: Center for Scientific is 1,899 hours. Time: 8:00 a.m. to 5:00 p.m. Review Special Emphasis Panel, Member Agenda: To review and evaluate grant Conflict: Alcohol, Drugs and References applications. Neurotoxicology. Place: National Institutes of Health, 6701 Date: March 2–3, 2016. The following references are on Rockledge Drive, Bethesda, MD 20892 Time: 8:00 a.m. to 12:00 p.m. display in the Division of Dockets (Virtual Meeting). Agenda: To review and evaluate grant Management (see ADDRESSES) and are Contact Person: Mehrdad Mohseni, MD, applications. available for viewing by interested Scientific Review Officer, Center for Place: National Institutes of Health, 6701 persons between 9 a.m. and 4 p.m., Scientific Review, National Institutes of Rockledge Drive, Bethesda, MD 20892 Monday through Friday; they are also Health, 6701 Rockledge Drive, Room 5211, (Virtual Meeting). available electronically at http:// MSC 7854, Bethesda, MD 20892, 301–435– Contact Person: Michael Selmanoff, Ph.D., www.regulations.gov. 0484; mohsenim@csr.nih.gov. Scientific Review Officer, Center for Name of Committee: Brain Disorders and Scientific Review, National Institutes of 1. Keller, Kevin L. and Donald R. Lehman, Clinical Neuroscience Integrated Review Health, 6701 Rockledge Drive, Room 5164, ‘‘Brands and Branding: Research Group, Diseases and Pathophysiology of the MSC 7844, Bethesda, MD 20892, 301–435– Findings and Future Priorities,’’ Visual System Study Section. 1119; selmanom@csr.nih.gov. Marketing Science, vol. 25, no. 6, pp. Date: February 25–26, 2016. Name of Committee: Center for Scientific 740–759, 2006. Time: 8:00 a.m. to 5:00 p.m. Review Special Emphasis Panel, PAR–13– 2. Eagly, Alice H. and Shelly Chaiken, Agenda: To review and evaluate grant 327: Innovative Molecular Analysis ‘‘Process Theories of Attitude Formation applications. Technology Development for Cancer and Change: Reception and Cognitive Place: Bahia Resort Hotel, 998 West Research and Clinical Care. Responding,’’ The Psychology of Mission Bay Drive, San Diego, CA 92109. Date: March 2, 2016. Attitudes, Chapter 6, Harcourt Brace Contact Person: Nataliya Gordiyenko, Time: 11:00 a.m. to 5:00 p.m. Jovanovich College Publishers, 1993. Ph.D., Scientific Review Officer, Center for Agenda: To review and evaluate grant Scientific Review, National Institutes of applications. Dated: January 27, 2016. Health, 6701 Rockledge Drive, Room 5202, Leslie Kux, Place: National Institutes of Health, 6701 MSC 7846, Bethesda, MD 20892, 301–435– Rockledge Drive, Bethesda, MD 20892. Associate Commissioner for Policy. 1265; gordiyenkon@csr.nih.gov. Contact Person: Zhang-Zhi Hu, MD, [FR Doc. 2016–01788 Filed 2–1–16; 8:45 am] Name of Committee: Oncology 2— Scientific Review Officer, Center for BILLING CODE 4164–01–P Translational Clinical Integrated Review Scientific Review, National Institutes of Group, Cancer Immunopathology and Health, 6701 Rockledge Drive, Room 6186, Immunotherapy Study Section. MSC 7804, Bethesda, MD 20892, (301) 594– Date: February 25–26, 2016. 2414; huzhuang@csr.nih.gov. DEPARTMENT OF HEALTH AND Time: 8:00 a.m. to 5:00 p.m. HUMAN SERVICES Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance applications. Program Nos. 93.306, Comparative Medicine, National Institutes of Health Place: The Dupont Hotel, 1500 New 93.333, Clinical Research, 93.306, 93.333, Hampshire Avenue NW., Washington, DC 93.337, 93.393–93.396, 93.837–93.844, Center for Scientific Review; Notice of 20036. 93.846– 93.878, 93.892, 93.893, National Closed Meetings Institutes of Health, HHS) wgreen on DSK2VPTVN1PROD with NOTICES Contact Person: Denise R Shaw, Ph.D., Scientific Review Officer, Center for Dated: January 27, 2016. Pursuant to section 10(d) of the Scientific Review, National Institutes of Federal Advisory Committee Act, as Michelle Trout, Health, 6701 Rockledge Drive, Room 6158, amended (5 U.S.C. App.), notice is MSC 7804, Bethesda, MD 20892, 301–435– Program Analyst, Office of Federal Advisory hereby given of the following meetings. 0198; shawdeni@csr.nih.gov. Committee Policy. The meetings will be closed to the Name of Committee: Oncology 1—Basic [FR Doc. 2016–01818 Filed 2–1–16; 8:45 am] public in accordance with the Translational Integrated Review Group, BILLING CODE 4140–01–P VerDate Sep<11>2014 15:21 Feb 01, 2016 Jkt 238001 PO 00000 Frm 00055 Fmt 4703 Sfmt 9990 E:\FR\FM\02FEN1.SGM 02FEN1


Document Created: 2016-02-02 00:32:05
Document Modified: 2016-02-02 00:32:05
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesFebruary 18, 2016.
FR Citation81 FR 5472 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR